A lupus drug and FDA approval

被引：0

|

作者：

Merrill, JT ^{[1
]}

Raymond, S ^{[1
]}

机构：

[1] Lupus Fdn Amer Inc, Washington, DC 20036 USA

来源：

SCIENCE | 2005年 / 308卷 / 5721期

关键词：

D O I：

暂无

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

收藏

页码：497 / 497

页数：1

相关论文

共 50 条

[41] FDA Revokes Approval for Preterm Birth Drug Makena
Harris, Emily
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (17): : 1444 - 1444
[42] FDA LOOKS TO SPEED UP DRUG APPROVAL PROCESS
BOOTH, W
SCIENCE, 1988, 241 (4872) : 1426 - 1426
[43] US - FDA to speed up drug approval process
不详
CHEMISTRY & INDUSTRY, 2003, (01) : 6 - 6
[44] FDA ANNOUNCES 4 INITIATIVES FOR DRUG APPROVAL SYSTEM
不详
CLINICAL PHARMACY, 1992, 11 (07): : 574 - &
[45] FDA UNDER PRESSURE TO EXPEDITE DRUG APPROVAL PROCESS
AGLER, HL
CHEMICAL ENGINEERING PROGRESS, 1995, 91 (08) : 28 - 28
[46] FDA GIVES CONDITIONAL APPROVAL TO CANINE LYMPHOMA DRUG
Cima, Greg
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2021, 258 (05): : 445 - 445
[47] FDA approval
不详
GERIATRICS, 2001, 56 (11) : 16 - 16
[48] FDA approval
不详
GERIATRICS, 2001, 56 (09) : 16 - 16
[49] FDA approval
不详
GERIATRICS, 2001, 56 (03) : 20 - 20
[50] A Comparison of FDA and EMA Drug Approval: Implications for Drug Development and Cost of Care
Howie, Lynn J.
Hirsch, Bradford R.
Abernethy, Amy P.
ONCOLOGY-NEW YORK, 2013, 27 (12): : 1195 - +

← 1 2 3 4 5 →